United States Files False Claims Act Complaint Against Drug Maker Teva Pharmaceuticals: Complaint alleges that Teva funneled hundreds of millions of dollars in kickbacks through co-pay foundations
BOSTON - The U.S. Attorney's Office has filed a complaint under the False Claims Act against Teva Pharmaceuticals USA, Inc., and Teva Neuroscience, Inc., the maker of Copaxone, a drug for multiple sclerosis (MS).
- Date:August 18, 2020
- Agency:U.S. Attorney's Office, District of Massachusetts
- Criminal and Civil Actions